PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Research demonstrates potential method to better control lung cancer using radiotherapy

Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients -- potentially offering improved local control and survival

2014-08-28
(Press-News.org) Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients – potentially offering improved local control and survival.

Standard treatment for locally advanced non-small cell lung cancer is a combination of radiotherapy and chemotherapy. Traditionally this is planned in a one-size-fits-all manner but the radiation dose may not always be enough to stop tumour growth.

The potential to increase the radiation dose to the cancerous tissue varies between patients and depends on the size and location of the tumour in relation to sensitive organs such as the spinal cord and lungs. Now researchers at The University of Manchester and The Christie NHS Foundation Trust – both part of the Manchester Cancer Research Centre – have looked at ways to personalise and increase the dose to the tumour while minimising the effect on healthy tissue.

Dr Corinne Faivre-Finn, researcher at The University of Manchester and Honorary Consultant at The Christie, who led the study, said: "Current standard options for the treatment of non-small cell lung cancer are associated with poor survival. We wanted to see if more advanced methods of planning and delivering radiotherapy treatment could potentially allow an increase in radiation dose."

The group used data from 20 lung cancer patients to investigate whether a newer radiotherapy technique – intensity modulated radiotherapy (IMRT) – could potentially be used to increase the radiation dose to lung tumours, without harming healthy organs. Their treatment planning methods ensured a safe radiation dose was delivered to the surrounding organs at risk.

In an article recently published in the journal Clinical Oncology, they show that IMRT allowed an increase in radiation dose for non-small cell lung cancer.

"Our exploratory study suggests that using IMRT can allow radiation dose to be increased: calculations indicate that this could yield a 10% improvement in tumour control. We are starting a new clinical trial, funded by Cancer Research UK, investigating the delivery of this personalised IMRT treatment in patients with non-small cell lung cancer. We hope to demonstrate that the increase dose delivered to the tumour will lead to improved survival " added Dr Faivre-Finn.

INFORMATION:


ELSE PRESS RELEASES FROM THIS DATE:

Dyslexic readers have disrupted network connections in the brain

2014-08-28
Philadelphia, PA, August 28, 2014 – Dyslexia, the most commonly diagnosed learning disability in the United States, is a neurological reading disability that occurs when the regions of the brain that process written language don't function normally. The use of non-invasive functional neuroimaging tools has helped characterize how brain activity is disrupted in dyslexia. However, most prior work has focused on only a small number of brain regions, leaving a gap in our understanding of how multiple brain regions communicate with one another through networks, called functional ...

Study shows where on the planet new roads should and should not go

2014-08-28
More than 25 million kilometres of new roads will be built worldwide by 2050. Many of these roads will slice into Earth's last wildernesses, where they bring an influx of destructive loggers, hunters and illegal miners. Now, an ambitious study has created a 'global roadmap' for prioritising road building across the planet, to try to balance the competing demands of development and environmental protection. The map has two components: an 'environmental-values' layer that estimates that natural importance of ecosystems and a 'road-benefits' layer that estimates the potential ...

Nanoscale assembly line

2014-08-28
This news release is available in German. Cars, planes and many electronic products are now built with the help of sophisticated assembly lines. Mobile assembly carriers, on to which the objects are fixed, are an important part of these assembly lines. In the case of a car body, the assembly components are attached in various work stages arranged in a precise spatial and chronological sequence, resulting in a complete vehicle at the end of the line. The creation of such an assembly line at molecular level has been a long-held dream of many nanoscientists. "It would ...

Paleontology: Oldest representative of a weird arthropod group

2014-08-28
Biologists at Ludwig-Maximilians-Universitaet (LMU) in Munich have assigned a number of 435-million-year-old fossils to a new genus of predatory arthropods. These animals lived in shallow marine habitats and were far less eye-catching than related forms found in Jurassic strata. Before they sank to the bottom of their shallow marine habitat and were fossilized some 435 million years ago, these arthropods preyed on other denizens of the Silurian seas – although they were not exactly inconspicuous, possessing a bivalved carapace and multiple abdominal limbs. A group of ...

Better classification to improve treatments for breast cancer

2014-08-28
Breast cancer can be classified into ten different subtypes, and scientists have developed a tool to identify which is which. The research, published in the journal Genome Biology, could improve treatments and targeting of treatments for the disease. Cancer arises due to genetic changes which cause normal cells to develop into tumors. As we learn more about breast cancer, we are seeing that it is not one single disease – the mutations in the genes that cause different cancers are not alike, and this is why tumors respond differently to treatment and grow at different ...

New study charts the global invasion of crop pests

New study charts the global invasion of crop pests
2014-08-28
Many of the world's most important crop-producing countries will be fully saturated with pests by the middle of the century if current trends continue, according to a new study led by the University of Exeter. More than one-in-ten pest types can already be found in around half the countries that grow their host crops. If this spread advances at its current rate, scientists fear that a significant proportion of global crop-producing countries will be overwhelmed by pests within the next 30 years. Crop pests include fungi, bacteria, viruses, insects, nematodes, viroids ...

The Lancet journals: Three-quarters of depressed cancer patients do not receive treatment for depression but a new approach could transform their care

2014-08-28
Three papers published in The Lancet Psychiatry, The Lancet, and The Lancet Oncology reveal that around three-quarters of cancer patients who have major depression are not currently receiving treatment for depression, and that a new integrated treatment programme is strikingly more effective at reducing depression and improving quality of life than current care. An analysis of data from more than 21 000 patients attending cancer clinics in Scotland, UK, published in The Lancet Psychiatry, found that major depression is substantially more common in cancer patients than ...

Better health care as important as controlling risk factors for heart health

2014-08-28
Hamilton, ON (August 27, 2014) – Keeping a healthy heart may have as much to do with the quality of health care you have available as it does you avoiding risk factors such as smoking, bad diet and little exercise. A large international study led by researchers at the Population Health Research Institute at McMaster University and Hamilton Health Sciences has found a that low-income countries which have people with the lowest risk factors for cardiovascular problems have the highest rates of cardiovascular events and death, while the high-income countries of people with ...

Researchers investigating new treatment for multiple sclerosis

2014-08-27
MINNEAPOLIS – A new treatment under investigation for multiple sclerosis (MS) is safe and tolerable in phase I clinical trials, according to a study published August 27, 2014, in Neurology® Neuroimmunology & Neuroinflammation, a new online-only, freely accessible, specialty medical journal. The publication is part of the Neurology® family of journals, published by the American Academy of Neurology. The phase I studies were the first to test the drug candidate in humans. Studies with animals showed that the drug, which is called anti-LINGO-1, or BIIB033, may be able to ...

Bundled approach to reduce surgical site infections in colorectal surgery

2014-08-27
Bottom Line: A multidisciplinary program (called a "bundle") that spanned the phases of perioperative care helped reduce surgical site infections (SSIs) in patients undergoing colorectal surgery (CRS) at an academic medical center. Author: Jeffrey E. Keenan, M.D., of the Duke University Medical Center, Durham, N.C., and colleagues. Background: SSIs are associated with increased complications, length of hospital stay, readmission rates and health care costs. Efforts that have used systematic approaches, called bundles, that aim to incorporate best practices across the ...

LAST 30 PRESS RELEASES:

New white paper on rebuilding trust at work amid AI-driven change and burnout published by University of Phoenix College of Doctoral Studies

How to motivate collective action on climate

Healing Hearts, Changing Minds awards $566,260 to seven projects to advance psychedelic-assisted end-of-life care

A novel rolling driving principle-enabled linear actuator for bidirectional smooth motion

Prognostic nutritional index predicts outcomes in hepatocellular carcinoma treated with atezolizumab and bevacizumab

Mountain snow and water forecasting tool developed by WSU researchers

Training the next generation of translational virologists: Reflections from the 2025 Global Virus Network Short Course

Should companies replace human workers with robots? New study takes a closer look

New study proposes global framework to safeguard world’s most vulnerable regions amid climate crisis

Interventions that promote collective climate action

Boston University receives grant from the Michael J. Fox foundation to study mechanisms of gait improvement in Parkinson’s disease

Trust in PhD advisor predicts a good grad school experience

Engineering and the quest for peace

Insilico Medicine and Qilu Pharmaceutical reach near $120 million drug development collaboration to accelerate novel cardiometabolic therapies

Chungnam National University develops AI model to accelerate defect-based material design

Identification of the central pathological substrate of bipolar disorder as paraventricular thalamic nucleus

A new route to synthesize multiple functionalized carbon nanohoops

Integrated smart contact lens technology for real-time intraocular pressure monitoring

New Boston University study identifies CTE as cause of dementia

Applied physics researchers explore impact of mathematically structured sound to selectively interact with cells.

New study redefines our understanding of how memory works

The most prominent trend in Holocaust commemoration worldwide is a growing focus on the rescuers of Jews

Prenatal exposure to air pollution is associated with lower cognitive performance in early childhood

AI learns better when it talks to itself

96% accurate footprint tracker for tiny mammals could help reveal ecosystem health

Balancing comfort and sustainability with climate-tailored housing

Not just sweet: the sugar branches that shape the brain

Spectral slimming for single-nanoparticle plasmons

Exploring the scientific connotation of the medicinal properties of toad venom (Chansu) — 'dispersing fire stagnation and opening orifices to awaken the spirit' — from the microscopic world of 5-HTR d

How early-career English language teachers can grow professionally, despite all odds

[Press-News.org] Research demonstrates potential method to better control lung cancer using radiotherapy
Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients -- potentially offering improved local control and survival